Penumbra, Inc.

PEN Healthcare Medical Devices

Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.

Revenue
+15.6%
EPS
−8.29%
Free cash flow
−37.2%
Total debt
−10.3%

Quarter to September 2026, against a year earlier

319.20 1.91 −0.59%
Market cap
$12.7B
P/E
80.3×
Fwd P/E
68.7×
Dividend yield
—
F-score
8/9
Altman Z
20.17
Beneish M
−2.48
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
132.03 710.86 643.16 117.34 0.00 1,915.47 0.00 104.16 641.84 68.03
Piotroski F-Score
3 6 7 5 2 6 1 8 5 8
Altman Z-Score
29.68 25.96 28.72 20.85 21.62 23.00 14.79 16.91 15.88 20.17
P/S ratio
7.41 8.93 9.38 10.43 11.17 14.13 9.88 8.88 7.68 8.62
P/FCF ratio
0.00 18,739.39 217.22 1,256.55 0.00 0.00 0.00 115.85 62.29 69.17
Altman Z″-Score (non-manufacturers)
11.51 10.09 9.23 7.25 7.54 6.47 5.88 7.10 6.72 8.59
Beneish M-Score
(1.29) (1.90) (2.45) (1.93) (2.35) (1.80) (1.91) (2.47) (3.11) (2.48)
P/Operating CF
(188.40) (3,285.07) 553.93 1,197.50 (3,004.91) (1,139.49) 6,260.77 259.22 179.52 139.91
P/B ratio
7.32 7.44 9.88 11.76 9.81 11.07 8.38 7.97 7.97 8.48
EV/Sales
6.92 8.28 8.92 10.13 10.74 13.82 9.69 8.63 7.41 8.25
EV/EBITDA
937.52 559.03 746.95 99.72 0.00 1,160.29 269.96 90.61 268.53 56.00
EV/FCF
(68.93) 17,389.76 206.76 1,220.75 (103.82) (884.97) (109.49) 112.58 60.13 66.17
Current Ratio
7.37 7.41 6.22 5.09 5.83 5.53 5.21 6.06 6.01 6.64
Net Debt/EBITDA
(66.23) (43.39) (37.79) (2.92) 10.10 (25.64) (5.37) (2.63) (9.65) (2.54)
Debt/Equity
0.00 0.00 0.00 0.06 0.04 0.03 0.02 0.02 0.02 0.01
ROE
5.94% 1.40% 1.60% 10.67% (2.80%) 0.66% (0.21%) 8.35% 1.20% 13.78%
ROA
5.18% 1.19% 1.33% 8.21% (2.11%) 0.51% (0.15%) 6.21% 0.91% 10.58%
ROIC
(0.61%) 0.39% (0.24%) 9.19% (6.08%) (0.65%) 0.45% 5.03% 0.70% 13.09%
Return on Tangible Assets
5.94% 1.29% 1.74% 11.43% (2.80%) 0.86% (0.30%) 10.87% 1.64% 15.44%
Average Days of Receivables
60.07 63.44 67.18 70.61 74.64 65.39 87.63 69.57 51.23 49.41
Earnings Yield
0.76% 0.14% 0.16% 0.85% (0.25%) 0.05% (0.03%) 0.96% 0.16% 1.47%
Free Cash Flow Yield
(1.36%) 0.01% 0.46% 0.08% (0.93%) (0.11%) (0.90%) 0.86% 1.61% 1.45%
Free Cash Flow per Share
(0.87) (0.07) 0.56 0.13 (1.62) (0.32) (1.98) 2.11 3.81 4.49
Book value per Share
8.75 12.14 12.37 13.97 17.83 25.95 26.40 30.70 29.79 36.68
Free Cash Flow
(26.44) (2.34) 19.21 4.54 (58.00) (11.68) (74.96) 81.13 147.30 174.93
EV/EBIT
0.00 2,373.37 0.00 116.74 0.00 0.00 1,349.47 124.18 954.45 61.17
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026